Register Login

PROFUSA, INC. (PFSA)

SymbolPFSA
NamePROFUSA, INC.
SectorHEALTH CARE
RegionNorth America
Industry-
Address94710 United States CA 626 Bancroft Way Suite A
Telephone+1 (925) 997-6925
Fax—
Email—
Websitehttps://profusa.com/
IncorporationUS
Incorporated On2021
Employees—
Fiscal Year12/31
Public Since—
ExchangesOTC;NASDAQ
Auditor—
Audit StatusAUDITED
Reporting StatusU.S. Reporting: SEC Reporting
CIK0001859807
Description

Profusa, Inc. is engaged in the development of a new generation of biointegrated sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.

Additional info from NASDAQ:
Profusa, Inc. is a commercial stage digital health company led by visionary scientific founders, an experienced management team and a world-class board of directors in the development of a new generation of tissue-integrated sensors to detect and continuously transmit actionable, medical-grade data for personal and medical use. With its long-lasting, injectable and affordable biosensors and its intelligent data platform, Profusa aims to provide people with a personalized biochemical signature rooted in data that clinicians can trust and rely on. "LUMEE", "PROFUSA" and the PROFUSA logo are registered trademarks of Profusa Inc. in the United States, Canada, European Union, China, Japan, South Korea and Australia.

Additional info from OTC:
Profusa, Inc. is engaged in the development of a new generation of biointegrated sensors that potentially empowers the individual with the ability to monitor their unique body chemistry.

2026-08-14 16:29

HRT FINANCIAL LP 🟡 adjusted position in 36.8K shares of Profusa, Inc. (PFSA) at $0.96 Transaction Date: Jul 28, 2026 | Filing ID: 000201

Read more
2026-08-13 11:00

Profusa Announces 1-for-4 Reverse Stock Split

Read more
2026-08-12 19:13

HRT FINANCIAL LP 🟡 adjusted position in 1.7K shares of Profusa, Inc. (PFSA) at $0.97 Transaction Date: Jul 28, 2026 | Filing ID: 000194

Read more
2026-08-10 19:39

HRT FINANCIAL LP 🟡 adjusted position in 381 shares of Profusa, Inc. (PFSA) at $0.95 Transaction Date: Jul 28, 2026 | Filing ID: 000191

Read more
2026-08-03 20:04

HRT FINANCIAL LP 🟢 acquired 9.9K shares of Profusa, Inc. (PFSA) at $1.05 Transaction Date: Jul 28, 2026 | Filing ID: 000183

Read more
2026-07-31 21:15

Profusa Announces Signing of Option Agreement for the Acquisition of a Commercial Stage Diagnostics Company, G3 Vision Labs

Read more
2026-07-31 20:56

(99% Neutral) PROFUSA, INC. (PFSA) Announces Business Combination

Read more
2026-07-30 19:00

HRT FINANCIAL LP 🟢 acquired 1.3K shares of Profusa, Inc. (PFSA) at $1.01 Transaction Date: Jul 28, 2026 | Filing ID: 000178

Read more
2026-07-30 15:58

New Form 3 - Profusa, Inc. <b>Filed:</b> 2026-07-30 <b>AccNo:</b> 0001475597-26-000177 <b>Size:</b> 4 KB

Read more
2026-07-27 10:08

(99% Neutral) PROFUSA, INC. (PFSA) Announces Business Combination

Read more
Trial ID Title Phase Indication Status Start Date Completion Date Source
NCT04514861 Monitoring Local Tissue Oxygen Changes Using the Wireless Lumee Oxygen Platform… Na Peripheral Artery Disease Active_Not_Recruiting 2020-12-18 2028-03-30 ClinicalTrials.gov
Total clinical trials: 1
Product Name Type Development Stage Therapeutic Area Study Status Trial ID
Wireless Lumee Oxygen Platform Other Approved Peripheral Artery Disease ACTIVE_NOT_RECRUITING NCT04514861
Wireless Lumee Oxygen Platform DEVICE Approved Peripheral Artery Disease ACTIVE_NOT_RECRUITING NCT04514861
Total products: 2